Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study

BMC Public Health

Table 3 Categorisation of the 55 thiazide advertisements by product(s) promoted

Thiazide advertised as:	Thiazide advertised
	indapamide N (%*)	hydrochlorothiazide N (%*)
Single agent thiazide pill	18 (15.9%)	0 (0%)
Single agent thiazide pill plus single agent ACE inhibitor pill	3 (2.7%)	0 (0%)
Combination thiazide/ACE inhibitor pill	0 (0%)	0 (0%)
Combination thiazide/angiotensin receptor blocker pill	0 (0%)	13 (11.5%)
Combination thiazide/ACE inhibitor pill plus single agent ACE inhibitor pill	14 (12.4%)	6 (5.3%)
Combination thiazide/angiotensin receptor blocker pill plus single agent angiotensin receptor blocker pill	0 (0%)	1 (0.9%)
Totals	35 (31%)	20 (17.7%)

* The numerator for the percentages is the 113 advertisements included in the study.

ISSN: 1471-2458